Dermapharm Holding SE (CHIX:DMPD) Institutional Ownership: 5.75% (As of Jul. 02, 2026)


CHIX:DMPD Dermapharm Holding SE CHIX:DMPD
80 GF Score
Price €46.18
GF Value €38.55
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Institutional Ownership?

Dermapharm Holding SE CHIX:DMPD 80 Institutional Ownership is 5.75% as of Jul. 02, 2026. GuruFocus rates CHIX:DMPD with a GF Score™ of 80/100 and a GF Value™ of €38.55. The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Dermapharm Holding SE's institutional ownership is 5.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Dermapharm Holding SE's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Dermapharm Holding SE's Float Percentage Of Total Shares Outstanding is 0.00%.

Dermapharm Holding SE Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE Institutional Ownership Chart

Dermapharm Holding SE Historical Data

The historical data trend for Dermapharm Holding SE can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 11.05 9.62 8.35 8.01 7.95 7.35 7.11 6.08 5.32 5.75
CHIX:DMPD
80GF Score
Dermapharm Holding SE CHIX:DMPD
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dermapharm Holding SE Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.75% mean?
Dermapharm Holding SE (CHIX:DMPD) has a Institutional Ownership of 5.75% as of Jul. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Dermapharm Holding SE and its competitors.
Is Dermapharm Holding SE's Institutional Ownership too high?
Dermapharm Holding SE's current Institutional Ownership is 5.75%. Overall, Dermapharm Holding SE has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Institutional Ownership compare to ZTS and UTHR?
Dermapharm Holding SE's Institutional Ownership of 5.75% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Dermapharm Holding SE and its competitors. Dermapharm Holding SE's current Institutional Ownership is 5.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Dermapharm Holding SE (CHIX:DMPD) has a current Institutional Ownership of 5.75%. The stock's GF Value™ is €38.55, compared to a current price of €46.18 — trading 19.8% above its estimated fair value. The current Institutional Ownership is 5.75%. Dermapharm Holding SE's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Dermapharm Holding SE (CHIX:DMPD), the current Institutional Ownership is 5.75% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (CHIX:DMPD) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.18 is trading 19.8% above its estimated GF Value™ of €38.55.

Key valuation signals for CHIX:DMPD:

  • Institutional Ownership: 5.75%
  • GF Value™: €38.55 vs. price of €46.18 (19.8% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the CHIX:DMPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Other Exchanges DMPHF:USA0A5J:UKDMP:Germany
Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
80GF Score

Get the complete analysis for CHIX:DMPD

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.18
Price
€38.55
GF Value